ICON Total Assets 2010-2025 | ICLR

ICON total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • ICON total assets for the quarter ending March 31, 2025 were $16.723B, a 1.91% decline year-over-year.
  • ICON total assets for 2024 were $16.878B, a 0.66% decline from 2023.
  • ICON total assets for 2023 were $16.99B, a 1.14% decline from 2022.
  • ICON total assets for 2022 were $17.185B, a 1.16% decline from 2021.
ICON Annual Total Assets
(Millions of US $)
2024 $16,878
2023 $16,990
2022 $17,185
2021 $17,387
2020 $3,436
2019 $2,908
2018 $2,354
2017 $2,147
2016 $1,826
2015 $1,717
2014 $1,529
2013 $1,442
2012 $1,202
2011 $1,035
2010 $950
2009 $908
ICON Quarterly Total Assets
(Millions of US $)
2025-03-31 $16,723
2024-12-31 $16,878
2024-09-30 $17,211
2024-06-30 $16,969
2024-03-31 $17,048
2023-12-31 $16,990
2023-09-30 $17,032
2023-06-30 $17,108
2023-03-31 $17,287
2022-12-31 $17,185
2022-09-30 $17,126
2022-06-30 $17,036
2022-03-31 $17,163
2021-12-31 $17,387
2021-09-30 $17,655
2021-06-30 $3,584
2021-03-31 $3,467
2020-12-31 $3,436
2020-09-30 $3,065
2020-06-30 $2,859
2020-03-31 $2,841
2019-12-31 $2,908
2019-09-30 $2,745
2019-06-30 $2,719
2019-03-31 $2,607
2018-12-31 $2,354
2018-09-30 $2,326
2018-06-30 $2,174
2018-03-31 $2,219
2017-12-31 $2,147
2017-09-30 $2,053
2017-06-30 $1,904
2017-03-31 $1,855
2016-12-31 $1,826
2016-09-30 $1,900
2016-06-30 $1,750
2016-03-31 $1,796
2015-12-31 $1,717
2015-09-30 $1,813
2015-06-30 $1,636
2015-03-31 $1,605
2014-12-31 $1,529
2014-09-30 $1,573
2014-06-30 $1,526
2014-03-31 $1,485
2013-12-31 $1,442
2013-09-30 $1,362
2013-06-30 $1,293
2013-03-31 $1,231
2012-12-31 $1,202
2012-09-30 $1,135
2012-06-30 $1,105
2012-03-31 $1,126
2011-12-31 $1,035
2011-09-30 $1,046
2011-06-30 $1,014
2011-03-31 $1,014
2010-12-31 $950
2010-09-30 $938
2010-06-30 $882
2010-03-31 $897
2009-12-31 $908
2009-09-30 $922
2009-06-30 $897
2009-03-31 $851
Sector Industry Market Cap Revenue
Medical Medical Services $11.753B $8.282B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $146.512B 27.48
Elevance Health (ELV) United States $86.065B 11.11
CVS Health (CVS) United States $83.137B 10.33
Cencora (COR) United States $55.558B 19.33
DiDi Global (DIDIY) China $23.015B 24.45
Natera (NTRA) United States $22.771B 0.00
BioMerieux (BMXMF) France $16.981B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.266B 0.00
Solventum (SOLV) United States $12.874B 13.63
CochLear (CHEOY) Australia $11.492B 0.00
Revvity (RVTY) United States $11.324B 19.49
Doximity (DOCS) United States $10.794B 49.97
Viatris (VTRS) United States $10.540B 3.62
Avantor (AVTR) United States $9.213B 13.39
HealthEquity (HQY) United States $9.042B 39.61
Medpace Holdings (MEDP) United States $8.689B 23.08
Sonic Healthcare (SKHHY) Australia $8.397B 0.00
Charles River Laboratories (CRL) United States $7.422B 14.54
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.425B 26.06
BrightSpring Health Services (BTSG) United States $3.848B 35.31
Sotera Health (SHC) United States $3.423B 19.45
Alignment Healthcare (ALHC) United States $3.055B 0.00
Surgery Partners (SGRY) United States $2.969B 38.62
Concentras Parent (CON) United States $2.811B 16.24
Organon (OGN) United States $2.620B 2.78
GeneDx Holdings (WGS) United States $2.006B 77.28
Ardent Health (ARDT) United States $1.908B 8.13
Progyny (PGNY) United States $1.859B 40.92
Premier (PINC) United States $1.853B 14.06
GoodRx Holdings (GDRX) United States $1.618B 32.36
PACS (PACS) United States $1.615B 0.00
Teladoc Health (TDOC) United States $1.302B 0.00
Pediatrix Medical (MD) United States $1.222B 9.29
CareDx (CDNA) United States $1.118B 17.46
Establishment Labs Holdings (ESTA) $1.114B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.948B 0.00
AMN Healthcare Services Inc (AMN) United States $0.844B 7.90
QDM (QDMI) Hong Kong, SAR China $0.763B 0.00
Nutex Health (NUTX) United States $0.671B 10.16
Embecta (EMBC) United States $0.591B 3.98
LifeMD (LFMD) United States $0.574B 0.00
Enhabit (EHAB) United States $0.519B 42.71
InnovAge Holding (INNV) United States $0.514B 0.00
SBC Medicals (SBC) United States $0.481B 0.00
Sonida Senior Living (SNDA) United States $0.474B 0.00
Auna S.A (AUNA) Luxembourg $0.462B 10.40
COMPASS Pathways (CMPS) United Kingdom $0.429B 0.00
Oncology Institute (TOI) United States $0.255B 0.00
Performant Healthcare (PHLT) United States $0.252B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
DocGo (DCGO) United States $0.156B 25.50
KindlyMD (KDLY) United States $0.150B 0.00
KindlyMD (NAKA) United States $0.111B 0.00
Pheton Holdings (PTHL) China $0.109B 0.00
So-Young (SY) China $0.091B 0.00
Basel Medical Group (BMGL) Singapore $0.077B 0.00
OncoCyte (OCX) United States $0.076B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.058B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Sera Prognostics (SERA) United States $0.057B 0.00
ModivCare (MODV) United States $0.052B 0.00
OpGen (OPGN) United States $0.050B 0.00
Biodesix (BDSX) United States $0.047B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Intelligent Bio Solutions (INBS) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00